Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

Leif Angelison, S. Almer, A. Eriksson, P. Karling, U. Fagerberg, J. Halfvarson, M. Thörn, J. Björk, U. Hindorf, R. Löfberg, A. Bajor, H. Hjortswang, P. Hammarlund, O. Grip, J. Torp, J. Marsal, E. Hertervig

Medicine/Emergency Medicine, Lund
Gastro
Internal Medicine - Epidemiology
Cardiology
Clinical studies af Atrial Fibrillation

Helsingborg Hospital

Research output: Contribution to journal › Article › peer-review

1 Letter

1 results

Filter

2017

Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply
Angelison, L., Marsal, J. & Hertervig, E., 2017 Apr 1, In: Alimentary Pharmacology and Therapeutics. 45, 8, p. 1177-1178 2 p.
Research output: Contribution to journal › Letter › peer-review

Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

Research output

Search results

Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply